Loading...

Cancer immunotherapy: exploiting neoepitopes

The efficacy of cancer vaccines has long been hampered by insufficient definition of tumor-specific antigens. A recent study by Kreiter et al. published in Nature has provided a blueprint for a patient-tailored approach to develop individualized RNA vaccines.

Saved in:
Bibliographic Details
Published in:Cell Res
Main Authors: Platten, Michael, Offringa, Rienk
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2015
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4528051/
https://ncbi.nlm.nih.gov/pubmed/26032267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cr.2015.66
Tags: Add Tag
No Tags, Be the first to tag this record!